← Open Payments lookup

TIMOTHY KIMUYU: Open Payments

NPI 1790203016 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,934 in 153 payments from 17 companies in 2025. Trend: 2023 $1,570 · 2024 $3,299 · 2025 $4,934

Food & beverage: $4,808Education: $126
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.27$1,124
Janssen Pharmaceuticals, Inc23$719
Teva Pharmaceuticals USA, Inc.24$674
Alkermes, Inc.20$627
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$496
Otsuka America Pharmaceutical, Inc.8$379
E.R. Squibb & Sons, L.L.C.10$205
ABBVIE INC.5$187
Vanda Pharmaceuticals Inc.8$171
Janssen Scientific Affairs, LLC1$138

Products named: INGREZZA, INVEGA SUSTENNA, CAPLYTA, ARISTADA, UZEDY, REXULTI, AUSTEDO XR, COBENFY.

Industry payments across TX — which companies pay providers there.